Latham & Watkins Advises Consonance Capital Partners on $856 Million Fund Formation

A New York-based Investment Funds team advised on the formation of Consonance Private Equity II.

April 27, 2020

Consonance Capital Partners, a leading U.S.-based healthcare private equity firm, has announced the final close of Consonance Private Equity II, L.P. (Fund II). Fund II closed at its hard cap of $856 million (inclusive of the GP commitment) in under three months from its initial close. Consistent with its predecessor fund, Fund II will focus on investments in U.S. healthcare companies in the lower and middle markets.

Latham & Watkins LLP advised Consonance Capital Partners on the fund formation with a team led by New York Investment Funds partner Andrea Schwartzman, with associates Erin Bergey, John Welling, and Connor Ross. New York partner Gregory Hannibal, with associate Eli McCrain, advised on tax matters.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.